Clinical Trials

CVRx touts positive two-year data for heart failure neuromodulation device

Building on long-term data announced earlier this year, CVRx has reported durable improvements in heart failure patients with its Barostim device over 24 months. The...

iRhythm has positive post-market study results for next-gen Zio

iRhythm Technologies announced initial research findings on its Zio monitor’s post-market, real-world performance. The company presented the data on its next-generation long-term continuous monitoring...

Median Technologies announces results of REALITY study of eyonis LCS lung cancer diagnostic

Median Technologies has announced that eyonis LCS, its proprietary AI/machine learning powered Software as a Medical Device (SaMD) for lung cancer screening (LCS), met...

New report supports SciBase’s melanoma detection AI device

Swedish medical detection company SciBase Holding has seen its artificial intelligence (AI) powered device for detecting melanomas, dubbed Nevisense, validated as part of a...

RenovoRx continues drug-device combo Phase III trial in pancreatic cancer

Another site has enrolled its first patient in RenovoRx’s Phase III trial evaluating a drug-device combination therapy to treat locally advanced pancreatic cancer. The latest...

Invenio completes enrolment in AI-based lung cancer imaging trial

California-based diagnostic imaging firm, Invenio Imaging, has announced that it has completed enrolment for a pivotal trial of its artificial intelligence (AI) driven software...

PhotoPharmics reaches a third of enrolment goal for PD light therapy trial

PhotoPharmics has enrolled the first 100 subjects in its clinical trial investigating a light therapy device designed for the treatment of Parkinson’s disease (PD). The...

Fractyl Health touts positive year-long weight loss results for Revita device

Fractyl Health has reported positive results for its hydrothermal ablation device Revita, as the company looks to battle the booming pharmaceutical weight loss therapy...

Galvanize concludes enrolment in study of Aliya PEF system for NSCLC

Galvanize Therapeutics has announced the completion of patient enrolment in the AFFINITY study assessing the Aliya pulsed electric field (PEF) system in treating late-stage...
1...151617...58Page 16 of 58

Latest articles